New cheaper insulin copy tested in healthy people
NCT ID NCT05539872
Summary
This study tested a new, potentially lower-cost copy (biosimilar) of a fast-acting insulin called NovoLog. The goal was to see if the new insulin behaves the same way in the body as the original. Healthy volunteers received both insulins in a carefully controlled setting to measure how they are absorbed and how they affect blood sugar.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amphastar Study Site
Chula Vista, California, 91911, United States
Conditions
Explore the condition pages connected to this study.